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Monocytes and macrophages contain, synthesize, and secrete a variety of enzymes 
active  at  acid  or  neutral  pH  (1).  The  enzyme  content  and  secretory  activity  of 
mononuclear phagocytes are related to the degree of cellular differentiation  and to 
the effects of exogenous stimuli. Resident peritoneal macrophages continuously secrete 
lysosomal  hydrolases  (2)  and  neutral  proteases  at  low  levels  (3-6).  Macrophages 
obtained from inflammatory exudates or stimulated by lymphokines or complement 
products  contain  and  secrete  increased  amounts  of lysosomal hydrolases  (2,  7,  8). 
Elicited or activated macrophages also synthesize greatly increased amounts of neutral 
proteases with secretion occurring after appropriate stimulation  (3-6, 9-1 1). 
Properties of macrophages are also modified by alterations in the surface to which 
they  adhere.  Macrophages  cultured  on  surfaces  coated  with  immune  complexes 
exhibit enhanced spreading (12)  and reduced phagocytosis of sensitized erythrocytes 
(13).  The effects of surface-bound immune complexes on enzyme secretion by mono- 
cytes or macrophages have not  been  examined.  Immune complexes are present  in 
articular  and  periarticular  tissues of patients  with  rheumatoid  arthritis  and  in  the 
glomeruli of patients with immunological renal disease. Mononuclear phagocytes are 
abundant in the proliferating tissue infiltrates found in rheumatoid arthritis (14) and 
may contribute  to  immune-mediated  glomerular  injury  (15).  Macrophage-derived 
enzymes are  capable of degrading  structural  elements  of articular  tissues  (16).  An 
analysis  of the  effects  of adherent  immune  complexes  on  human  monocytes  and 
macrophages may yield information relative to pathophysiological events in human 
diseases. 
In this  paper we confirm that  human  peripheral  monocytes release plasminogen 
activator during in vitro culture. When exposed to surface-bound immune complexes, 
however, the monocytes exhibit a burst of plasminogen-independent enzyme activity, 
and no plasminogen activator secretion occurs. Studies with enzyme inhibitors reveal 
that plasminogen-independent  fibrinolysis is due primarily to the release of elastase- 
like enzymes from the human monocytes. In addition,  deiodinating enzyme activity 
is observed when human monocytes interact with surface-bound immune complexes. 
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Materials  and  Methods 
Materials.  Dulbecco's Modified Eagle's Medium  (DME), 1 Hanks'  balanced salt solution 
(HBSS), and fetal calf serum (FCS) were purchased from Grand Island Biological Co., Grand 
Island, N. Y. Ficoll-Hypaque, Sephadex G-200 and G-100 were obtained from Pharmacia Fine 
Chemicals,  Piscataway,  N.  J.  Plasminogen-free bovine  fibrinogen,  human  serum  albumin 
(HSA),  and  rabbit  albumin  were  purchased  from  Miles  Laboratories  Inc.,  Elkhart,  Ind. 
Lactalbumin hydrolysate (LH) was obtained from ICN Nutritional Biochemicals Div., Cleve- 
land, Ohio, and trypsin and soybean trypsin inhibitor (STI) from Worthington Biochemical 
Corp.,  Freehold, N. J.  Epsilon-amino caproic acid  (EACA), diaminobenzoic acid  (DABA), 
alpha-chymotrypsin, pork pancreatic elastase, urokinase, pepstatin A, casein, and elastin Congo- 
red were obtained from Sigma Chemical Co., St. Louis, Mo. Streptokinase-streptodornase (SK- 
SD)  was  purchased  from  Lederle Laboratories, Pearl  River, N.  Y.  Dr. John  Powers of the 
Georgia Institute of Technology kindly provided Ac-AIa-Ala-Pro-ValCH2C1, MeO-Suc-Ala- 
AIa-Pro-ValCH2CI, and Z-GIy-Leu-PheCH2C1. Dr. John D. Lonsdale-Eccles and Dr. Kenneth 
Waish of the University of Washington generously supplied us with Tos-PheCH2CI (TPCK), 
Tos-LysCH2CI (TLCK), and di-isopropylfluorophosphate (DFP). Through  them we also ob- 
tained elastatinal and chymostatin from  Dr. Walter Troll of New York University Medical 
Center, New York. 
Preparation  of Cells.  Mononuclear  leukocytes  (MNL)  were  obtained  by  Ficoll-Hypaque 
centrifugation of whole blood anticoagulated with  EDTA.  The  MNL were washed once in 
saline buffered with 0.05 M  phosphate (PBS) containing 1 mM EDTA, then twice in HBSS. 
The cells were counted and diluted in DME with 0.05%  lactalbumin hydrolysate (DME-LH) 
to contain 2  ×  106 MNL/ml.  15-20%  of these cells contained peroxidase granules (17)  and 
ingested latex particles (18).  About 1% were polymorphonuclear neutrophils (PMN) as deter- 
mined by examination of Wright's stained smears. More than 95% of the MNL were viable as 
determined by exclusion of trypan blue dye. These MNL preparations were applied to 125I- 
fibrin substrates as described below. 
For some experiments,  MNL  isolated from  70-150  ml  blood were cultured overnight  in 
siliconized glass culture vessels. The medium was then decanted, and the vessel was incubated 
for 10 min in ice-cold PBS containing 10 mM EDTA to induce resuspension of adherent cells. 
The PBS and medium were pooled and centrifuged again on Ficoll-Hypaque gradients. The 
MNL were washed as outlined above, and their concentration was adjusted to contain 300,000 
peroxidase-positive cells/ml. 8-12% of these MNL contained peroxidase granules, and >90% 
excluded trypan blue. 
Purified PMN were obtained by Ficoll-Hypaque centrifugation and dextran sedimentation 
(19).  These  preparations contained  >95%  PMN,  and  the  cells were >98%  viable.  Purified 
lymphocytes were obtained after nylon wool filtration of MNL (20). 
Preparation ofa25I-Fibrin Substrates.  125I-Fibrin plates were prepared by the method of Gordon 
et al. (21).  Plasminogen-free bovine fibrinogen (500-1,000 cpm//~g) was dissolved in PBS and 
diluted with distilled water to 333/~g/ml. For the formation of immune complexes, HSA was 
added  as  antigen  to  some  of the  fibrinogen so  that  its final concentration  was  33  /tg/ml. 
Aliquots of fibrinogen or fibrinogen-HSA (0.3 ml) were dispensed into 35-mm plastic culture 
dishes, spread with a sterile glass rod, and dried at 45°C for 2 d. Before use, the fibrinogen was 
converted to fibrin by a  2-h incubation with HBSS containing 10% FCS, and the plates were 
washed twice with HBSS. About 90% of the counts applied were adherent after this incubation, 
and  1-2% were solubilized in the absence of cells over 3-6 h. Trypsin digestion removed >98% 
of the counts from the plates. 
For preparation of ~2~I-fibrin plates containing surface-bound immune complexes, 1 ml of 
1 Abbrew'ations used in this paper: DABA, diaminobenzoic acid; DFP, di-isopropylfluorophosphate;  DME, 
Dulbecco's Modified Eagle's Medium; DMSO, dimethylsulfoxide; EACA, epsilon-aminocaproic acid; FCS, 
fetal calf serum; HBSS, Hanks' balanced salt solution; HSA, human serum albumin; ICs0, 50% inhibitory 
concentration;  LH, lactalbumin hydrolysate; MNL, mononuclear  leukocyte(s); PBS, phosphate-buffered 
saline; PMA, phorbol myristate acetate;  PMN, polymorphonuclear  neutrophil(s);  SK-SD, streptokinase- 
streptodornase; STI, soybean trypsin inhibitor; TLCK, Tos-LysCH2CI; TPCK, Tos-PheCH2C1. 956  NEUTRAL PROTEASE SECRETION BY  HUMAN MONOCYTES 
rabbit IgG anti-HSA at  100 #g/ml was added to each plate to be sensitized for 15 min at room 
temperature. The plates were then washed twice with HBSS. Studies with labeled HSA showed 
that about 2 p,g of HSA was adherent after the 2-h incubation with serum, and  75% remained 
adherent  over  a  9-h  incubation  in  DME.  About  2  #g  of anti-HSA  adhered  to  the  plates 
containing HSA, and  <0.2 #g adhered  to plain  fibrin substrates.  The presence of HSA and 
immune  complexes did  not  affect  the adherence  or stability of fibrin.  The  incorporation  of 
immune  complexes  into  the  substrate  did  not  affect  SK-activated  plasminogen-dependent 
fibrinolysis. 
Plasminogen  was  isolated  from  outdated  human  plasma  by  the  method  of Deutsch  and 
Mertz  (22).  Anti-HSA  was  purified  by  affinity  chromatography  from  rabbit  antisera,  and 
monomeric IgG antibodies were obtained by gel filtration on Sephadex G-200 (23). 
Assay of Fibrinolysis.  1-ml  vol of MNL were  added  in  triplicate  to  35-mm  culture  dishes 
coated with 12sI-fibrin alone or with 125I-fibrin  incorporating surface-bound immune complexes. 
Human plasminogen (8-10 pg/ml) was added to some cultures. Enzyme inhibitors were added 
in some experiments  as  well, and  when  needed,  1%  dimethylsulfoxide  (DMSO)  was used  to 
enhance  the  solubility  of  the  inhibitors.  DMSO  did  not  affect  the  observed  fibrinolysis. 
Fibrinolysis was measured  for 3  h  as  the cells settled  onto  the substrates.  At the end  of this 
incubation period, the medium was collected and counted along with a  1-ml wash. The plates 
were then washed four times with warm HBSS to remove loosely adherent cells. Less than  1% 
of the counts was removed by these washes.  The remaining cells and substrate  were digested 
with trypsin overnight at 37°C. The trypsin digest and a  1-ml wash were counted to determine 
the  amount  of residual  radioactivity.  The  ratio  of 12sI-fibrin  solubilized  to  the  total  counts 
initially adherent was calculated and expressed as the percent fibrinolysis. Correction was made 
for the amount of radioactivity solubilized in the absence of the cells. 
In some experiments, the cells were not removed after 3 h, but DME-LH was again added, 
with or without plasminogen, and the fibrinolytic assay was continued for another 6-18  h.  In 
these experiments, 50-#1 aliquots of the medium were withdrawn at intervals to study the time- 
course of fibrinolysis. After the extended fibrinolytic period, the medium and a  1-ml wash were 
aspirated  and counted. The plates were then digested with trypsin as outlined above. 
For correlation of fibrinolysis with cell number,  the DNA content of the trypsin digests was 
determined by the method of Kissane and Robins (24). The trypsin aspirate was made 0.4% in 
rabbit  albumin, and the total protein was precipitated by adding  1 ml of cold 20% trichloroa- 
cetic acid. In the extended experiments, the medium collected at the end of the experiment was 
treated  in  the same  fashion  as  the  trypsin  digest.  Lipids  were  extracted  with  0.2-ml  vol of 
alcoholic  potassium  acetate  and  ethanol.  Fluorescence  was  developed  with  0.18  ml  of 2  N 
DABA in  HCI.  The  reaction  product  was  diluted  to  1 ml  with  0.6  N  perchloric  acid,  and 
fluorescence was  read  in  a  Perkin-Elmer  spectrofluorometer  (Perkin-Elmer  Corp.,  Norwalk, 
Conn.)  at  510 nm with excitation set at  419 nm against  a  salmon  DNA standard.  This assay 
recovered ---85% of 2  ×  105 MNL  (1 /zg)  digested in the culture dishes along with the fibrin 
substrate.  Under standard  assay conditions,  0.5-2.2 ~g of cellular DNA was adherent  at  3 h. 
About  10% of the cellular DNA was lost over the subsequent  6  h  and a  further  15% was lost 
over 6-21  h.  Cell  loss  was  similar  from  monolayers  on  plain  fibrin  or on  fibrin-containing 
immune complexes. 
When fibrinolytic activity was correlated with DNA content, it was expressed as fibrinolytic 
units  (percent  fibrinolysis per microgram  DNA).  Plasminogen-independent  fibrinolytic units 
were  calculated  by  dividing  mean  percent  fibrinolysis  by  mean  monolayer  DNA  content. 
Plasminogen-dependent  fibrinolytic units  were calculated  in  the same way after subtracting 
plasminogen-independent  activity. 
In experiments with enzyme inhibitors,  inhibition of plasminogen-independent  fibrinolysis 
was determined with the following formula: 
mean percent fibrinolysis with inhibitor 
Percent inhibition  --  1  mea-"-n  percen'---'~  fibrinolysi-'-----~  witho-----ut  inhibit'---'~r,] ×  100. 
Inhibition of plasminogen-dependent  fibrinolysis was calculated  in the same way after correc- 
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Chromatographic Analysis of Supernates.  Supernates for chromatographic analysis were obtained 
under assay conditions described above, except that the 125I-fibrinogen  used in the preparation 
of plates contained 25,000 cpm//~g. Cells were obtained from three separate donors for assay 
under each set of conditions. The supernates were analyzed for the presence of free iodide by 
the  method  of Klebanoff and  Green  (25).  Duplicate  25-/~i aliquots of the supernates  were 
applied to 1-in. wide strips of  Whatman no. 1 filter paper, and ascending paper chromatography 
was performed for 18 h with a butanol acetic acid solvent system. A control strip with leSI-Na 
was run with each set of test samples. The strips were dried, cut into 0.5-in sections starting 
at  the origin, and  counted.  The  radioactivity present  in each strip that  migrated with  the 
mobility of free iodide was calculated. The amount of free iodide in the supernate was expressed 
as  a  percentage  both  of the  total  counts  per  minute  in  the  supernate  and  of the  total 
radioactivity present in the system (i.e., in the supernate and remaining on the plate). 
Determination of Activity of Enzyme Inhibitors in the Absence of Cells.  Chymostatin was assayed by 
the method of Umezawa and Aoyagi (26).  The 50% inhibitory concentration (ICs0) obtained 
with bovine alpha-chymotrypsin and casein as substrate was 0.24/~g/ml, indicating that our 
preparation  was  of comparable potency  to  that  described.  Elastatinal was  assayed by  the 
method of Umezawa and Aoyagi (26) with porcine pancreatic elastase and elastin Congo-red. 
The IC~0 obtained for thisinhibitor was  17.8/xg/ml, a potency about  10% of that described~ 
Inhibition of urokinase by chymostatin was determined with a cell-free 125I-fibrin plate assay. 
Urokinase, 0.1  or 0.5  U/rnl  in  0.1  M  Tris HCI,  pH  8,  was  incubated with chymostatin in 
amounts  ranging  from  0  to  240  pg/ml  for  30  min  at  room  temperature.  The  urokinase- 
chymostatin mixtures (0.5 ml) were then added to  16-ram plastic wells coated with x25I-fibrin 
(20 pg x25I-fibrinogen/well and 2,500  epm//Lg). 2/tg plasminogen was added to each well, and 
the wells were incubated at 37°C for 1 h. Percent fibrinolysis and inhibition of fibrinolysis were 
determined as described for assays with cells. In the presence of plasminogen and in the absence 
of inhibitors, 0.1  U  of urokinase led to solubilization of 5% of the counts  in  1 h  and 0.5  U 
solubilized 20%. 
Inhibition  of plasmin  by  cbymostatin  was  determined  in  a  similar  assay  except  that 
plasminogen  (2.0 p,g/ml) was activated with SK-SD (1  U/ml)  for 30 min at 37°C  in plastic 
tubes. Chymostatin at 240/xg/ml was added, and the tubes were incubated at room temperature 
for 30 min. Fibrinolysis was then measured with ~25I-fibrin-coated 16-mm wells with an assay 
period of 30 min. 60% of the counts were solubilized by SK-activated plasminogen during this 
time. 
Results 
Cell Populations and Morphology.  Approximately 1% of the MNL obtained by Ficoll- 
Hypaque centrifugation were  PMN  and  15-20%  of the MNL  contained peroxidase 
granules. 90% of the cells that were bound to a  fibrin substrate after 3 h  of adherence 
and washing contained peroxidase granules and took up latex particles. Up to 2% of 
the adherent cells were PMN by morphological criteria. Examination of the monocytes 
adherent  to  a  plain  fibrin  substrate  showed  most  of  the  cells  to  be  rounded  in 
appearance. 
The population of cells bound to a  fibrin substrate containing immune complexes 
differed. Up to 2% of the cells were PMN, but only 65% appeared to be monocytes by 
the criteria of peroxidase positivity and latex particle uptake. At 3 h, many of the cells 
incubated on surface-bound immune complexes were spread and had long cytoplasmic 
extensions. The DNA contents of monolayers incubated on  the two substrates were 
equivalent. 
Only 3% of MNL  recovered after passage through a  nylon wool column contained 
peroxidase granules and took up latex particles. 
Fibrmolysis  by  MNL  on  Plain  Fibrin.  MNL  plated  onto  a  12~I-fibrin substrate  ex- 
hibited a  continuous pattern of fibrinolysis that was largely plasminogen dependent, 958  NEUTRAL  PROTEASE  SECRETION  BY  HUMAN  MONOCYTES 
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Fro.  I.  Eibrinolysis exhibited by MNL (2  X  10  c') plated onto 125I-fibrin  (upper panel) or msI-fibrin 
with adherent  immune complexes (lower panel). The cumulative percent fibrinolysis is plotted  vs. 
the  time  of incubation.  At  3  h  the  plates  were  washed  to  remove  nonadherent  cells,  and  fresh 
medium  was  instilled.  Experiments  with  both  substrates were  performed  in  the  presence  (O)  or 
absehce  (O)  of plasminogen.  Cells  in  contact  with  surface-bound  immune  complexes  show  no 
plasminogen-dependent activity. 
reflecting secretion of plasminogen activators  (Fig.  I). This fibrinolysis was propor- 
tional  to MNL cell number  (Fig.  2).  The same relationship  was seen if the percent 
fibrinolysis  was  plotted  against  the  DNA  content  of the  adherent  cells  (data  not 
shown). Similar patterns of fibrinolysis were observed in 33 separate experiments with 
cells from 14 donors. The amount of plasminogen-dependent fibrinolysis varied from 
donor to donor by a  factor of three to four and from day to day in single donors by 
a  factor  of two  to  three  when  expressed  either  in  terms  of MNL  cell  number  or 
monolayer DNA content.  Results from the 33 experiments showed fibrinolysis in the 
absence and presence of plasminogen to be 5.6  -  3.5 and 23.5  -+  14.0%  (mean  -+  1 
SD), respectively, when measured 3 h after plating of cells. 
Fibrinolysis by Monocytes on Fibrin with Adherent Immune Complexes.  When MNL were 
plated  onto  125I-fibrin  incorporating  HSA-anti-HSA  immune  complexes  vigorous 
plasminogen-independent fibrinolysis was observed. High activity was observed soon 
after plating of cells, but very little further fibrinolysis occurred after washing of the 
monolayers at 3 h  (Fig.  1). This plasminogen-independent fibrinolysis was elicited by 
2 #g/plate  of antibody in  immune complexes.  The same activity was  elicited  to a 
lesser degree when large amounts of antigen were dried onto the surface. None of this 
activity was elicited when plain fibrin plates were sensitized with anti-HSA (Table I). 
From  32 experiments with  cells cultured  on surface-bound immune complexes, the 
plasminogen-independent  fibrinolysis averaged  28.5  --+  12.0%  (+ 1 SD)  during  the 
first 3 h. 
When high plasminogen-independent activity was elicited, plasminogen-dependent 
activity was absent, as in the case of MNL incubated on complexes, or diminished, as 
when  cells  were  in  contact  with  high  amounts  of antigen  (Table  I).  No  return  of CAROL  GODOSHIAN  RAGSDALE  AND  WILLIAM  P.  AREND 
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FIG.  2.  Effect  of MNL  cell  number  on  fibrinolysis.  The  percent  cumulative  fibrinolysis  in  the 
presence (O)  or absence (O) of plasminogen is plotted, with serially increasing numbers of MNL, as 
indicated on the figure. 
plasminogen-dependent  activity was observed even when cells plated onto complexes 
were washed and fibrinolysis was allowed to continue for another 18 h  (Fig.  1). 
Conditions  eliciting  plasminogen-independent  fibrinolysis  affected  cell  viability. 
Although >95%  of MNL incubated on a  plain fibrin substrate excluded trypan blue 
dye at 21  h, viability of MNL incubated on surface-bound complexes averaged 90% 
at3h,  85%at9h,  and 66%  at 21h. 
Fibrinolysis by Purified Lymphocytes and PMN.  Because the adherent cell populations 
on the two substrates differed and the preparations contained a  trace contamination 
with  PMN,  the  fibrinolytic  activities  of nylon  wool-purified  lymphocytes  and  of 
isolated PMN were measured to determine the possible contribution of these cells to 
the fibrinolysis observed with the MNL preparations. 
The MNL eluted from a nylon wool column contained 97% lymphocytes. A portion 
of these cells adhered to surface-bound immune complexes but did not produce any 
detectable fibrinolysis  (Table II). 
Purified  PMN  produced  an amount of plasminogen-dependent  fibrinolysis equal 
to that seen with MNL when enzyme activity was correlated with the DNA content 
of the adherent cells (Table III). However, far more plasminogen-independent activity 
was  elicited  from  PMN  than  from  MNL  incubated  on  surface-bound  complexes. 
When fibrinolytic activity was correlated with monolayer DNA content, PMN were 
three  to  four times  more active  than  adherent  MNL  (Table  III).  This  experiment, 960  NEUTRAL  PROTEASE  SECRETION  BY  HUMAN  MONOCYTES 
TABLE  I 
Effect of Immune Complexes on Plasminogen-Dependent and Independent Fibrinolysis Induced by MNL * 
Plate incu- 
HSA in sub-  bated with 
strate  anti-HSA 
Percent fibrin'olysis¢  Fibrinolytic units§ 
Without  With  Plasminogen  Plasminogen 
plasminogen  plasminogen  independent  dependent 
pg dried~plate 
0  -  1.9 ±  0.2  23.2  +  0.6  1.0  10.7 
0  +  3.8  :Is 0.5  29.9  +  0.9  1.7  11.7 
10  -  6.0  +  1.5  19.8  +  2.5  2.6  5.9 
10  +  30.1  :t:  1.0  29.2  +  1.2  11.9  0 
50  -  11.7  ±  0.7  17.9  +  0.2  5.1  2.7 
50  +  31.3  ±  0.5  31.9  +  1.0  13.2  0.3 
* 1-ml vol of MNL (2  ×  106/ml)  were dispensed onto plates containing 12zI-fibrin with or without HSA io 
varying amounts. Some plates were incubated with anti-HSA before the addition of cells. Fibrinolys~ 
was assayed for 3 h. 
The percent fibrinolysis is expressed as the mean  +  1 SD based upon results from three replicate plates. 
§ Fibrinolytic units  of activity  were  calculated  by  correlating  plasminogen-dependent or  independent 
fibrinolysis with monolayer DNA content, as described in Materials and Methods. 
TABLE  II 
Comparbon of Fibrinolytic Activities of MNL and Purified Lymphocytes* 
Immune com- 
Cell type  plexes present 
Percent fibrinolysis  Fibrinolytic units 
Without  With  Plasminogen  Plasminogen 
plasminogen  plasminogen  independent  dependent 
MNL  -  2.7  +  0.4  23.2  +  0.8  5.9  44.6 
Lymphocytes  -  0  0  0  0 
MNL  +  23.0  ±  1.0  22.7  +  1.0  40.4  0 
Lymphocytes  +  1.5  :tz 0.1  2.6  +  0.8  2.1  1.2 
* MNL (1  X  10S/ml)  and purified lymphocytes (4  X  106/ml)  were added to plates coated with l~l-fibrin 
with or without immune complexes. 
TABLE  III 
Comparison of Fibrinolytic Activities of MNL and Purified Neutrophils* 
Immune  Percent fibrinolysis  Fihrinolytic units 
Cell 
type  complexes  Without  With  Plasminogen  Plasminogen 
present  plasminogen  plasminogen  independent  dependent 
MNL  -  4.1  ~  0.1  26.2  +  1.3  5.7  30.7 
PMN  -  8.5  +  0.2  15.4  ±  2.8  26.6  20.6 
MNL  +  28.3  +  0.0  35.0  +  0.8  30.1  7.1 
PMN  +  67.4  +  0.5  70.2  +  1.6  107  4.4 
* MNL (2 X  10S/ml)  and purified PMN (2  x  105/ml)  were added to plates coated with 125I- 
fibrin with or without adherent immune complexes. 
however,  would  tend  to  underestimate  the  activity  of the  monocytes;  lymphocytes 
constitute  35%  of the  monolayer  cells  and  would  add  significantly  to  the  adherent 
DNA  content  without  contributing  any fibrinolytic activity. The  possible contribution 
of PMN  to the fibrinolysis observed  with  MNL  was further  assessed after depletion  of 
PMN  in overnight  culture. CAROL GODOSHIAN  RAGSDALE AND WILLIAM  P.  AREND 
TABLE  IV 
Effect of Protease Inhibitors on Plasminogen-Dependent and Independent Fibrinolysis* 
961 
Inhibitor:~  Concentration 
Plasminogen-depend- 
ent fibrinolysis 
Plasminogen-inde- 
pendent fibrinolysis§ 
Percent  Percent 
inhibition  inhibition  Percent  Percent 
inhibition  corrected  inhibition  corrected 
for DNA  for DNA 
content  content 
EACA (1)  1.0 mM  100  100  0  0 
DFP (3)  0.1 mM  36  23  56  62 
1.0 mM  96  94  69  78 
STI (3)  20 ~g/ml  75  68  ND  ND 
50 #g/ml  100  87  ND  ND 
100 #g/ml  100  100  38  40 
600/lg/ml  ND  ND  48  44 
a-l-Antitrypsin (1)  100/~g/ml  46  ND  40  ND 
300 #g/ml  ND  ND  44  ND 
Chymostatin (3)  0.1 mM  70  66  19  31 
Elastatinal (2)  0.1 mM  0  0  0  0 
Pepstatin A (3)  0.01 mM  0  0  0  0 
0.1 mM  ND  ND  0  0 
TLCK (2)  0.1 mM  15  0  3  17 
MeO-Suc-Ala-Ala-  0.1 mM  6  0  45  54 
Pro-ValCH2CI  (3)  1.0 mM  ND  ND  45  48 
Ac-Ala-Ala-Pro-  0.1 mM  0  0  26  25 
ValCH2CI (1) 
* MNL  (2  ×  10S/ml) were plated onto  12zI-fibrin with or without  incorporated  immune 
complexes.  Inhibition was calculated as the percent reduction in plasminogen-dependent 
or independent fibrinolysis or as the percent reduction in fibrinolysis expressed  in fibrino- 
lytic units (i.e., corrected for the DNA content of the cell monolayers).  ND indicates that 
the measurement was not done. 
The number of experiments with each inhibitor is indicated in parentheses.  When multiple 
experiments were performed, the data are expressed as the mean. 
§ No correction was made for the amount of deiodination. 
Fibrinolysis  by  MNL  Freed of PMN.  MNL  were  incubated  at  37°C  overnight  in 
siliconized  glass  culture  vessels,  then  harvested  and  centrifuged  again  on  Ficoll- 
Hypaque  gradients.  These preparations  contained no PMN  among  200 cells counted. 
Fibrinolysis  was  compared  with  that  of fresh  MNL  obtained  from  the  same  donor. 
With  cell  concentrations  adjusted  so  that  the  MNL  preparations  contained  equal 
numbers  of peroxidase-positive  cells,  fibrinolysis of the two  preparations  on  surface- 
bound  complexes was identical. We concluded that  monocytes were the major source 
of the enzyme activity observed  in MNL  and  not  lymphocytes or the small numbers 
of PMN  present. 
Characterization of the Enzyme  Activities.  The  enzymes  responsible  for  the  observed 
fibrinolytic activities were further characterized by including protease inhibitors with 
known specificities in the culture medium  before the plating of cells. The inclusion of 
inhibitors  (with two exceptions)  did not affect cell viability as determined  by trypan 
blue dye exclusion or monolayer DNA  content. 
Plasminogen-dependent  fibrinolysis was abolished by EACA, STI, and DFP  (Table 962  NEUTRAL  PROTEASE  SECRETION  BY  HUMAN  MONOCYTES 
TAnLE V 
Deiodination by MNL * 
Immune corn-  Plasminogen  Enzyme inhibitors  Percent  apparent 
plexes present  present  present  fibrinolysis~ 
Amount of free iodide as a 
percentage of§ 
Soluble radio-  Total radio- 
activity  activity 
--  D 
--  + 
+ 
+  + 
+ 
+ 
None  4.8 +  1.2  27.1  +  4.3  1.2 +  0.3 
None  9.7 +  3.9  19.2 ±  3.1  1.8 ±  0.4 
None  24.4 +  7.4  43.9 +  1.5  11.4 ±  3.5 
None  28.5 ±  6.5  38.9 ±  6.3  11.4 +  4.5 
DFP (1 mM)  8.3 ±  1.3  48.9 +  7.2  4.1  +  1.3 
MeO-Suc-Ala-Ala-  18.2 +  3.3  62.8 +  5.5  11.5 ±  3.2 
Pro-ValCH2CI 
(0.1 mM) 
STI (600 gg/ml)  16.3 +  2.8  62.9 +  9.6  10.5 ±  3.4 
* MNL from three donors were plated onto 12%fibrin  with or without adherent immune complexes, and 
the supernates were analyzed for the presence of free iodide as described in Materials and Methods. The 
data  are expressed as the mean  ±  1 SD of the results obtained with three plates under each set of 
conditions. 
:~ The apparent percent fibrinolysis  was not corrected for deiodination. 
§ The free iodide in the supernate is expressed as a percentage of the soluble radioactivity (counts per 
minute in the supernate) and of the total radioactivity (counts per minute in the supernate and remaining 
on the plate). 
IV).  Plasminogen-dependent fibrinolysis was also inhibited 70%  by 0.1  mM chymo- 
statin, an inhibitor of chymotrypsin-like enzymes (26). Cell-free fibrinolysis activated 
by urokinase was also inhibited by chymostatin in amounts comparable to that which 
inhibited cell-mediated plasminogen-dependent fibrinolysis. Plasmin was not directly 
inhibited by chymostatin. Two other  inhibitors of chymotrypsin-like enzymes, the 
chloromethyl ketones TPCK and Z-Gly-Leu-PheCH2CI,  were toxic to MNL, reducing 
monolayer viability by 50%  and adherence by 90%.  No  inhibition of plasminogen- 
dependent fibrinolysis was observed in the presence of pepstatin A, an inhibitor of 
acid proteases (26), the elastase inhibitor elastatinal (26), or TLCK  (Table IV). 
Plasminogen-independent fibrinolytic activity was reduced 69% by DFP, 48% by 
STII, and 40% by alpha-l-antitrypsin (Table IV). The elastase inhibitors MeO-Suc- 
Ala-Ala-Pro-ValCH2Cl and Ac-Ala-Ala-Pro-ValCH2Cl inhibited activity by 45 and 
26%,  respectively,  and  chymostatin inhibited  19%.  No  inhibition of plasminogen- 
independent fibrinolysis was observed in the presence of EACA, pepstatin A, elasta- 
final, or TLCK. When MNL were incubated overnight before assay of plasminogen- 
independent fibrinolysis,  an identical degree of inhibition  was observed in the presence 
of MeO-Suc-Ala-Ala-Pro-ValCH2C1. There was no augmentation of inhibition when 
chymostatin and  MeO-Suc-Ala-Ala-Pro-ValCH2C1 were  assayed  together,  nor was 
there significant recovery of plasminogen-dependent activity. 
Deiodination by Monocytes.  As no protease inhibitor reduced plasminogen-independ- 
ent fibrinolysis by >70%, we investigated the possibility that nonproteolytic enzyme 
activity was being detected in these assays. 
Analysis by ascending paper chromatography of supernatant media from MNL in 
contact with surface-bound complexes revealed that 39-44% of the soluble radioactiv- 
ity (representing 11.4%  of the total radioactivity) migrated with the mobility of free 
iodide (Table V).  When MNL were incubated on fibrin without adherent immune CAROL GODOSHIAN RAGSDALE AND WILLIAM P.  AREND  963 
complexes, <2% of the total radioactivity was solubilized as free iodide. The enzyme 
inhibitors  STI and  MeO-Suc-AIa-Ala-Pro-ValCH2C1 did  not  affect  the  amount  of 
free iodide solubilized when expressed as the percentage of total radioactivity although 
there were increases in  the relative amounts of free iodide in  the supernates.  When 
cells on immune complexes were incubated in the presence of DFP, there was a  65% 
decrease in free iodide solubilized. 
Discussion 
When the surface to which human peripheral monocytes adhere is modified by the 
incorporation  of immune complexes, the cells exhibit  differences in  the nature  and 
pattern of neutral enzyme secretion from what has been generally noted with resident, 
elicited, or activated animal macrophages. Fibrinolysis by monocytes in contact with 
unmodified 12~I-fibrin is largely plasminogen dependent, proceeds linearly with time, 
and reflects the continuous secretion of plasminogen activator, as has been described 
by others (11). Such monocytes also exhibit a minor continuous degree ofplasminogen- 
independent  fibrinolysis. When  monocytes are incubated on surface-bound immune 
complexes, however, a  burst of plasminogen-independent  fibrinolysis occurs.  Under 
these conditions,  plasminogen-dependent  fibrinolysis is absent  and  does not  emerge 
even when the plasminogen-independent activity diminishes to the background levels 
of unstimulated  monocytes.  Plasminogen-independent  fibrinolysis  is  also  elicited  if 
large amounts of albumin, another surface-bound phagocytic stimulus, are dried onto 
the  surface.  This  pattern  of  fibrinolysis  is  similar  to  that  observed  with  PMN 
stimulated with phorbol myristate acetate (PMA) (27). A lower degree ofplasminogen- 
independent  fibrinolysis also was  observed by Vassalli  et  al.  (28)  in  mouse  macro- 
phages stimulated with PMA. 
Critical  in  our studies  is  the  identification  of the  monocyte as  the  source of the 
plasminogen-independent  enzyme activity observed with  MNL preparations.  PMN 
constituted about 1% of the total cells and 5-7% of the peroxidase-positive cells in the 
MNL. The cells adherent  to the fibrin substrate contained 2% or less  PMN, but the 
possibility  exists  that  PMN  in  the  supernate  interacted  with  the  surface-bound 
complexes  and  contributed  to  the  observed  fibrinolysis.  Purified  PMN  exhibited 
three- to fourfold greater levels of activity in comparison with the MNL preparations 
when  fibrinolysis was correlated with cellular DNA contents.  When  MNL prepara- 
tions  were  cultured  overnight,  the  number  of cells  possessing stainable  peroxidase 
granules was reduced by one-half and no PMN were identified.  In cell preparations 
adjusted to contain equal numbers of peroxidase-positive cells, fresh MNL and MNL 
incubated  overnight  exhibited  identical  levels of plasminogen-independent  fibrino- 
lyric activity during  3-h culture  on surface-bound complexes.  In addition,  purified 
lymphocytes showed  no  fibrinolytic  activity when  plated  on  the  complexes.  These 
results support the conclusion that the observed plasminogen-independent fibrinolysis 
was due to enzymes released from monocytes in the MNL preparations. 
The  reasons  for  the  absence  of plasminogen  activator  secretion  from  the  cells 
cultured  on immune complexes are not  known.  It is unlikely that  the plasminogen 
activator was destroyed by other enzymes as no plasminogen-dependent  fibrinolysis 
emerged even when the cells were cultured  for an additional  18 h  after a  change in 
culture medium, During this time, plasminogen-independent  activity was no higher 
than  that  of cells  cultured  on  plain  fibrin.  Cytoplasmic  inhibitors  of plasminogen 964  NEUTRAL  PROTEASE SECRETION BY HUMAN MONOCYTES 
activators have been described in rabbit endothelial cells (29)  but no free inhibitors 
were detected in the supernates of cultured mouse peritoneal macrophages (3).  The 
reduction in viability seen with monocytes cultured on immune complexes may signify 
cell  damage  sufficient  to  lead  to  the  observed  decrease  in  plasminogen  activator 
secretion. The localization of plasminogen activators in macrophages and the mech- 
anisms of increased secretion from elicited or activated cells are not  known.  If this 
enzyme is present primarily in the plasma membrane, as has been described in rabbit 
endothelial  cells  (29)  and  guinea  pig  mast  cells  (30),  culturing  of monocytes on 
surface-bound  immune  complexes  may  have  led  to  an  inhibition  of mobility  or 
turnover  of  membrane  constituents.  Mouse  peritoneal  macrophages  cultured  on 
surface-bound immune complexes exhibit a selective membrane immobilization man- 
ifest by a  loss  of Fc-triggered phagocytosis (13). In addition, mixed B  lymphocytes 
and macrophages plated on immobilized immune complexes display an inhibition of 
mitogenesis (31) and a decrease in proliferation into antibody-forming cells (32). 
The fibrinolytic enzymes released from the human monocytes in our studies were 
further characterized  by  mixing  protease  inhibitors  with  cells  before culturing.  A 
limitation of this technique, however, is that inhibition of enzyme activities might be 
incomplete in  the  microenvironment of cells plated  directly onto the substrate.  In 
addition, the possibility cannot be excluded that  added  inhibitors reduced enzyme 
secretion rather than enzyme activity or affected a  step in enzyme activation. This 
technique has an advantage, however, in that it permits analysis of enzyme activities 
from  small  numbers  of  cells  without  the  potential  losses  induced  by  handling 
conditioned medium or cell lysates. 
Plasminogen-dependent fibrinolysis was abolished by DFP, EACA, and STI. DFP 
and EACA are known to inhibit plasmin as well as plasminogen activators, whereas 
STI inhibits only plasmin (33).  Chymostatin inhibited plasminogen-dependent fibri- 
nolysis by 70%.  Fibrinolysis activated by urokinase in  the absence of cells was  also 
inhibited to a similar degree, indicating that the chymostatin did not simply reduce 
plasminogen activator secretion. Furthermore, chymostatin was  found by ourselves 
and  others  to  have  no  direct  inhibitory  effects  on  plasmin  (26).  Thus,  at  the 
concentrations used in our experiments, chymostatin was a selective inhibitor of both 
urokinase  and  monocyte-derived  plasminogen  activators.  At  these  concentrations 
chymostatin also  inhibits  proteases other than  chymotrypsin and  cathepsin  G  (26, 
34). Therefore, inhibition of plasminogen activators does not imply that these enzymes 
are chymotrypsin-like. Evidence from other studies  indicates that  cell-derived plas- 
minogen activators have a trypsin-like substrate specificity (33).  Plasminogen activa- 
tors, however, are not  inhibited by STI or other macromolecular trypsin inhibitors 
(33).  Further  study  of the  interaction  of chymostatin  and  plasminogen  activators 
might help to elucidate the active sites of these enzymes. 
The  plasminogen-independent  fibrinolysis  seen  in  our  studies  with  monocytes 
incubated on surface-bound immune complexes was inhibited 69% by DFP and 48% 
by STI. The chloromethyl ketones specific for leukocyte elastase (35), MeO-Suc-Ala- 
AIa-Pro-ValCH2CI  and  Ac-AIa-AIa-Pro-ValCH2C1,  inhibited  45  and  26%,  respec- 
tively, of this activity. These results suggest that the predominant monocyte protease 
is similar to leukocyte elastase.  Elastatinal  was  not  inhibitory, but  the preparation 
used in our studies  had  only  10% of the activity toward pancreatic elastase as has 
been reported for this compound (26).  Furthermore, elastatinal is weakly inhibitory CAROL GODOSHIAN RAGSDALE AND WILLIAM P.  AREND  965 
toward leukocyte elastase in comparison to its effect on porcine pancreatic elastase 
(34).  20-30% inhibition of plasminogen-independent fibrinolysis by chymostatin was 
observed. At the concentrations used in our experiments, the chymostatin could be 
inhibiting a chymotrypsin-like enzyme such as cathepsin G  (34) or partially blocking 
elastase. The absence of additive inhibitory effects with chymostatin and MeO-Suc- 
Ala-AIa-Pro-ValCH2C1 suggests the latter possibility. 
Up  to 45% of the plasminogen°independent  fibrinolysis produced by monocytes 
cultured on surface-bound immune complexes represented deiodination rather than 
proteolysis. Intracellular deiodination may be due to the activity of myeloperoxidase 
(36), which is found in the azurophilic granules of both monocytes and PMN (37, 38). 
Under certain conditions, myeloperoxidase may be active in the extracellular envi- 
ronment (36) although the site of deiodination in our experiments was not elucidated. 
The total amounts of deiodination were not  reduced by STI or MeO-Suc-Ala-Ala- 
Pro-ValCH2CI, whereas the relative amounts of free iodide in the culture supernates 
were increased. These results indicate that the inhibitors were affecting plasminogen- 
independent fibrinolytic proteases and not the deiodinating enzymes. The reduction 
in total deiodination in the presence of DFP could reflect reduced secretion or a direct 
inhibition of the deiodinating enzymes, or could indicate a  requirement for partial 
proteolysis to precede deiodination. A role for deiodinating enzymes in the induction 
of tissue injury has not been defined although the activity of such enzymes must be 
considered in the in vitro study of phagocytic cells and iodinated substrates.  Under 
certain experimental conditions, deiodination could be mistaken for proteolysis. 
An  elastaselike enzyme with  a  pattern  of response to inhibitors characteristic of 
leukocyte elastase has not previously been described in monocytes. The elastase found 
in conditioned medium from mouse peritoneal macrophages is not inhibited by STI 
and it is secreted in a continuous fashion (5). Monocytes stain weakly with naphthol 
AS-D chloroacetate (39), a histochemical substrate for leukocyte elastase and cathepsin 
G  (40).  Monocytes also  stain,  again  weakly,  with  a  fluoresceinated  antiserum  to 
leukocyte elastase (41). PMN show strong histochemical and immunological reactivity. 
Similarly, the level of elastaselike activity of PMN in our studies was threefold greater 
than  that  observed with monocytes. The azurophilic granules of the PMN contain 
peroxidase, elastase, and cathepsin G  (37). It is probable that  the deiodinating and 
elastaselike enzymes described in the human monocytes in our studies were derived 
from  a  similar  intracellular  structure.  Azurophilic  granules  are  lost  as  monocytes 
mature into macrophages, reflected in a  disappearance of stainable peroxidase (38) 
and probably also of stainable esterase. 
Monocyte- or macrophage-derived neutral proteases may play an important role in 
tissue  destruction  in  human  diseases  where surface-bound  immune  complexes are 
present. Fibrin degradation products derived from proteases other than plasmin have 
been  identified  in  rheumatoid  synovium  and  synovial  fluid  (42).  Although  serum 
protease inhibitors may inactivate enzymes in body fluids, their effectiveness may be 
much reduced in the microenvironment of a cell directly adherent to the tissue injured 
(43). Increased numbers of immature monocytes are found in the blood of patients 
with  rheumatoid  arthritis  or  systemic  lupus  erythematosus  (44).  Newly  recruited 
monocytes may interact with adherent immune complexes in the joints or glomeruli 
of these  patients,  stimulating  the  release of neutral  enzymes capable of degrading 
collagen, elastin,  and  proteoglycans  (40).  More mature macrophages  in  the  tissues 966  NEUTRAL PROTEASE SECRETION BY HUMAN MONOCYTES 
may  have  a  different  pattern  of enzyme  release.  Further  studies  are  necessary  to 
characterize  the  response of human  macrophages in  various stages of activation or 
differentiation to surface-bound immune complexes. 
Summary 
The effect of surface-bound immune complexes on the secretion of neutral proteases 
by human  peripheral  monocytes was  examined.  Monocytes cultured  on  12sI-fibrin 
secreted plasminogen activator in a continuous fashion. Monocytes incubated on 125I- 
fibrin  with  surface-bound  immune  complexes  displayed  a  burst  of plasminogen- 
independent  fibrinolytic  activity, whereas  no  release  of plasminogen  activator was 
observed  through  21  h.  The  plasminogen-independent  fibrinolytic  enzymes  were 
derived  from monocytes and  not  from lymphocytes or contaminating polymorpho- 
nuclear  neutrophils.  The  effects of various  protease  inhibitors  on  the  secretion  of 
plasminogen-dependent  and  independent  enzymes  were  determined.  Chymostatin 
selectively inhibited  the monocyte-derived plasminogen activators. Similar effects of 
chymostatin were observed on human urokinase in the absence of cells. The predom- 
inant protease producing plasminogen-independent fibrinolysis exhibited responses to 
inhibitors characteristic of leukocyte elastase. When monocytes were cultured on 125I- 
fibrin with adherent immune complexes ---40% of the solubilized radioactivity repre- 
sented  deiodination  and  not  proteolysis.  It  was  concluded  that  culture  of human 
monocytes on surface-bound immune complexes stimulates the secretion of plasmin- 
ogen-independent  fibrinolytic proteases, primarily elastase,  and of deiodinating  en- 
zymes. Under these conditions, plasminogen activator secretion is inhibited.  Neutral 
proteases secreted from newly recruited monocytes may contribute to tissue injury in 
human diseases characterized by the presence of adherent immune complexes. 
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